Vaxart (VXRT) Misses Q1 EPS by 2c

Vaxart (NASDAQ: VXRT) reported Q1 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $2.18 million versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance